v3.25.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net loss $ (3,022) $ (4,562)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of deferred compensation 20 33
Stock-based compensation expense 1,893 732
Depreciation and amortization expense 415 311
Amortization of discount on convertible notes 715
Changes in fair value of derivative liabilities 278
Changes in operating assets and liabilities:    
Accounts receivable (902) 129
Prepaids and other current assets (611) (2)
Accounts payable 44 (144)
Accrued expenses and other current liabilities 22 48
Net cash used in operating activities (1,148) (3,455)
Investing activities:    
Purchase of equipment (161) (322)
Net cash used in investing activities (161) (322)
Financing activities:    
Repurchase of common stock (4)
Proceeds from stock option exercise 25
Proceeds from convertible notes issuance 3,145
Proceeds from Public Offering, net of offering costs 12,588
Net cash provided by (used in) financing activities 15,758 (4)
Net change in cash and cash equivalents, and certificate of deposit 14,449 (3,781)
Cash and cash equivalents, and certificate of deposit, beginning of period 1,291 5,072
Cash and cash equivalents, and certificate of deposit, end of period 15,740 1,291
Supplemental non-cash disclosures:    
Conversion of convertible notes to stockholders’ equity 1,667
Conversion of derivative liabilities to stockholders’ equity $ 2,471

Source